A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 7, 2013, Pages 634-642

  Wen, Z ^a   Liao, Q ^a   Hu, Y ^a   You, L ^a   Zhou, L ^a   Zhao, Y ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Drug testing; Pancreatic cancer; Spheroid; Three dimensional culture

Indexed keywords

ACID PHOSPHATASE; FLUOROURACIL; GEMCITABINE;

ARTICLE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSCOPY; MODEL; PANCREAS CANCER; SPHEROID BASED 3 D CULTURE MODEL; SURVIVAL RATE; TUMOR SPHEROID;

ANIMALIA;

ACID PHOSPHATASE; ANTIMETABOLITES, ANTINEOPLASTIC; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; DRUG SCREENING ASSAYS, ANTITUMOR; FLUOROURACIL; HUMANS; PANCREATIC NEOPLASMS; SPHEROIDS, CELLULAR;

EID: 84881604704     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20132647     Document Type: Article

References (39)

1. Neoptolemos JP. Adjuvant treatment of pancreatic cancer. Eur J Cancer 2011; 47 (Suppl 3): S378-S380. doi: 10.1016/ S0959-8049(11)70210-6.
2. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006; 7: 211-224. doi: 10.1038/nrm1858.
3. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, et al. Engineering complex tissues. Tissue Eng 2006; 12: 3307-3339. doi: 10.1089/ten.2006.12.3307.
4. Burdett E, Kasper FK, Mikos AG, Ludwig JA. Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng Part B Rev 2010; 16: 351-359. doi: 10.1089/ ten.teb.2009.0676.
5. Sutherland RM, Durand RE. Radiation response of multicell spheroids -an in vitro tumour model. Curr Top Radiat Res Q 1976; 11: 87-139.
6. Durand RE. Multicell spheroids as a model for cell kinetic studies. Cell Tissue Kinet 1990; 23: 141-159.
7. Durand RE, Olive PL. Evaluation of bioreductive drugs in multicell spheroids. Int J Radiat Oncol Biol Phys 1992; 22: 689-692. doi: 10.1016/0360-3016(92)90504-B.
8. Groebe K, Erz S, Mueller-Klieser W. Glucose diffusion coefficients determined from concentration profiles in EMT6 tumor spheroids incubated in radioactively labeled Lglucose. Adv Exp Med Biol 1994; 361: 619-625. doi: 10.1007/978-1-4615-1875-4_114.
9. Sakai S, Inamoto K, Liu Y, Tanaka S, Arii S, Taya M. Multicellular tumor spheroid formation in duplex microcapsules for analysis of chemosensitivity. Cancer Sci 2012; 103: 549-554. doi: 10.1111/j.1349-7006.2011.02187.x.
10. Montel F, Delarue M, Elgeti J, Malaquin L, Basan M, Risler T, et al. Stress clamp experiments on multicellular tumor spheroids. Phys Rev Lett 2011; 107: 188102. doi: 10.1103/ PhysRevLett.107.188102.
11. Ho WJ, Pham EA, Kim JW, Ng CW, Kim JH, Kamei DT, et al. Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci 2010; 101: 2637-2643. doi: 10.1111/j.1349-7006.2010.01723.x.
12. Kruttwig K, Brueggemann C, Kaijzel E, Vorhagen S, Hilger T, Lowik C, et al. Development of a three-dimensional in vitro model for longitudinal observation of cell behavior: monitoring by magnetic resonance imaging and optical imaging. Mol Imaging Biol 2010; 12: 367-376. doi: 10.1007/ s11307-009-0289-x.
13. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 2004; 9: 273-285. doi: 10.1177/1087057104265040.
14. Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids -old hat or new challenge? Int J Radiat Biol 2007; 83: 849-871. doi: 10.1080/09553000701727531.
15. McLeod EJ, Beischer AD, Hill JS, Kaye AH. Multicellular tumor spheroids grown from pancreatic carcinoma cell lines: use as an orthotopic xenograft in athymic nude mice. Pancreas 1997; 14: 237-248. doi: 10.1097/00006676-199704000-00004.
16. Sweigert SE, Alpen EL. Dynamics of cell kinetic parameters during 9L spheroid growth. Cell Tissue Kinet 1986; 19: 567-576.
17. Sutherland RM, McCredie JA, Inch WR. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 1971; 46: 113-120.
18. Friedrich J, Eder W, Castaneda J, Doss M, Huber E, Ebner R, et al. A reliable tool to determine cell viability in complex 3-D culture: the acid phosphatase assay. J Biomol Screen 2007; 12: 925-937. doi: 10.1177/1087057107306839.
19. Kunz-Schughart LA, Groebe K, Mueller-Klieser W. Threedimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation. Int J Cancer 1996; 66: 578-586. doi: 10.1002/(SICI)1097-0215(19960516)66:4,578::AID-IJC25.3.0.CO;2-2.
20. Drewitz M, Helbling M, Fried N, Bieri M, Moritz W, Lichtenberg J, et al. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol J 2011; 6: 1488-1496. doi: 10.1002/biot.201100290.
21. Cichon MA, Gainullin VG, Zhang Y, Radisky DC. Growth of lung cancer cells in three-dimensional microenvironments reveals key features of tumor malignancy. Integr Biol 2012; 4: 440-448. doi: 10.1039/c1ib00090j.
22. Barbone D, Yang TM, Morgan JR, Gaudino G, Broaddus VC. Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem 2008; 283: 13021-13030. doi: 10.1074/jbc.M709698200.
23. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 2004; 14: 43-47. doi: 10.1016/j.gde.2003.11.007.
24. Desoize B, Jardillier J. Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol 2000; 36: 193-207. doi: 10.1016/S1040-8428(00)00086-X.
25. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-KlieserW, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 2010; 148: 3-15. doi: 10.1016/j.jbiotec.2010.01.012.
26. Elliott NT, Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 2011; 100: 59-74. doi: 10.1002/jps.22257.
27. Liao Q, Hu Y, Zhao YP, Zhou T, Zhang Q. Assessment of pancreatic carcinoma cell chemosensitivity using a threedimensional culture system. Chin Med J 2010; 123: 1871-1877.
28. Sempere LF, Gunn JR, Korc M. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFb in pancreatic cancer cells. Cancer Biol Ther 2011; 12: 198-207. doi: 10.4161/cbt.12.3.15979.
29. Enmon R, Yang WH, Ballangrud AM, Solit DB, Heller G, Rosen N, et al. Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids. Cancer Res 2003; 63: 8393-8399.
30. Fehlauer F, Muench M, Rades D, Stalpers LJ, Leenstra S, van der Valk P, et al. Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration. J Cancer Res Clin Oncol 2005; 131: 723-732. doi: 10.1007/s00432-005-0014-3.
31. Lambert B, de Ridder L, Slegers G, De Gelder V, Dierckx RA, Thierens H. Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma. Can J Physiol Pharmacol 2004; 82: 146-152. doi: 10.1139/y04-008.
32. Shield K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol Oncol 2009; 113: 143-148. doi: 10.1016/j.ygyno.2008.11.032.
33. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc 2009; 4: 309-324. doi: 10.1038/ nprot.2008.226.
34. Khaitan D, Chandna S, Arya MB, Dwarakanath BS. Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med 2006; 4: 12. doi: 10.1186/1479-5876-4-12.
35. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 2009; 69: 5820-5828. doi: 10.1158/0008-5472.CAN-08-2819.
36. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE. Development and characterization of gemcitabineresistant pancreatic tumor cells. Ann Surg Oncol 2007; 14: 3629-3637. doi: 10.1245/s10434-007-9583-5.
37. Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M, et al. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res 2005; 11: 3094-3101. doi: 10.1158/1078-0432.CCR-04-1785.
38. Zhang Q, Zhao YP, Liao Q, Hu Y, Xu Q, Zhou L, et al. Associations between gene polymorphisms of thymidylate synthase with its protein expression and chemosensitivity to 5-fluorouracil in pancreatic carcinoma cells. Chin Med J 2011; 124: 262-267.
39. Kurata N, Fujita H, Ohuchida K, Mizumoto K, Mahawithitwong P, Sakai H, et al. Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil. Int J Oncol 2011; 39: 473-482.